Report: Cancer in Estonia: morbidity and survival (Estonia): Difference between revisions

From Beacon
No edit summary
No edit summary
Line 13: Line 13:


'''Access to information:''' [https://www.tai.ee/sites/default/files/2022-05/Vähk_Eestis_haigestumus_2019_ja_elulemus_2015_2019.pdf Click here to access].
'''Access to information:''' [https://www.tai.ee/sites/default/files/2022-05/Vähk_Eestis_haigestumus_2019_ja_elulemus_2015_2019.pdf Click here to access].
{{Mouth}}
{{Throat}}
{{Oropharynx}}
{{Nasopharynx}}
{{Hypopharynx}}
{{Larynx}}
{{Salivary glands}}
{{Lips}}
{{Tonsils}}
{{base of tongue}}
{{Voice box}}
{{Esophagus}}
{{Stomach}}
{{Small intestine}}
{{Large intestine}}
{{Colon}}
{{Rectum}}
{{Anus}}
{{Liver}}
{{Gallbladder}}
{{Bile ducts}}
{{Pancreas}}
{{Lung}}
{{Trachea}}
{{Bronchi}}
{{Pleura}}
{{Mediastinum}}
{{Bone}}
{{Cartilage}}
{{Osteosarcoma}}
{{Ewings sarcoma}}
{{Skin}}
{{Melanoma}}
{{Scalp}}
{{Lips}}
{{Hands}}
{{Feet}}
{{Muscle}}
{{Fat}}
{{Tendon}}
{{Ligament}}
{{Blood vessels}}
{{Connective tissue}}
{{Sarcoma}}
{{Angiosarcoma}}
{{Liposarcoma}}
{{Lobular}}
{{Breast}}
{{Nipple}}
{{Areola}}
{{Ductal}}
{{Vulva}}
{{Vagina}}
{{Cervix}}
{{Uterus}}
{{Ovary}}
{{Fallopian tubes}}
{{Endometrium}}
{{Prostate}}
{{Testicles}}
{{Penis}}
{{Kidney}}
{{Ureter}}
{{Bladder}}
{{Urethra}}
{{Eye}}
{{Brain}}
{{Spinal cord}}
{{Thyroid gland}}
{{Parathyroid}}
{{Adrenal glands}}
{{Pituitary gland}}
{{Pancreas}}
{{Thymus gland}}
{{Peritoneum}}
{{Pericardium}}
{{Retroperitoneum}}
{{Mesothelium}}
{{Blood}}
{{Bone marrow}}
{{Lymph nodes}}
{{Spleen}}
{{Leukemia}}

Revision as of 20:05, 10 September 2024

Go back to Estonia page

Primary purpose: To provide comprehensive and up-to-date cancer incidence statistics in Estonia, based on data from the cancer registry, enabling analysis of cancer survival and scientific research.

Sponsor, manager or home institution: Tervise Arengu Instituut.

Type of information: More common cancer sites; cancer incidence and morbidity; Distribution of primary cases by cancer site and spread at diagnosis; Cancer prevalence and survival. Click here to learn more.

Data level: national level.

Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.

Access to information: Click here to access.